Initial Double Sequential External Defibrillation in Out of Hospital Cardiac Arrest
Recruiting
N/A
Interventional Study
Cardiac Arrest
Out-Of-Hospital Cardiac Arrest
Ventricular Fibrillation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 356 (estimated)
- Sponsor
- St. Olavs Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Double Sequential External Defibrillation (DSED) represents an alternative treatment of refractory ventricular fibrillation (rVF) in out-of-hospital cardiac arrest (OHCA). The procedure consists of two defibrillators that administer shocks at the same time.
Currently, the procedure is not initiated before at least three failed attempts with one defibrillator. This can delay the potential benefits…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with out of hospital cardiac arrest presenting with a shockable rhythm
Exclusion Criteria:
* Age below 18 years
* Obvious or suspected pregnancy
* Incarcerated patients
* Preexisting do-not-resuscitate order
Contacts